Back to Search
Start Over
High rate of event-free survival at 24 months with everolimus/RCHOP for untreated diffuse large B-cell lymphoma: updated results from NCCTG N1085 (Alliance).
- Source :
-
Blood cancer journal [Blood Cancer J] 2017 Jun 23; Vol. 7 (6), pp. e576. Date of Electronic Publication: 2017 Jun 23. - Publication Year :
- 2017
- Subjects :
- Antibodies, Monoclonal, Murine-Derived administration & dosage
Antibodies, Monoclonal, Murine-Derived adverse effects
Antineoplastic Combined Chemotherapy Protocols adverse effects
Cyclophosphamide administration & dosage
Cyclophosphamide adverse effects
Disease-Free Survival
Doxorubicin administration & dosage
Doxorubicin adverse effects
Everolimus adverse effects
Female
Humans
Male
Prednisone administration & dosage
Prednisone adverse effects
Rituximab
Survival Rate
Vincristine administration & dosage
Vincristine adverse effects
Antineoplastic Combined Chemotherapy Protocols administration & dosage
Everolimus administration & dosage
Lymphoma, Large B-Cell, Diffuse drug therapy
Lymphoma, Large B-Cell, Diffuse mortality
Subjects
Details
- Language :
- English
- ISSN :
- 2044-5385
- Volume :
- 7
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Blood cancer journal
- Publication Type :
- Report
- Accession number :
- 28649983
- Full Text :
- https://doi.org/10.1038/bcj.2017.57